supply of srphc82151020-glycopyrrolate 0.2mg/ml inj 1ml amp [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] achd/drug.store/rh/per, sr - 1) srphc82151025-glycopyrolate 0.5 mg + neostigmine methyl sulphate 2.5 mg inj 5 ml amp, 2) srphc82151020-glycopyrrolate 0.2mg/ml inj 1 ml amp, 3) srphc82185434-glycopyrrolate 25mcg inhalation solution of 1ml respule s, 4) srphc82185450 glycopyrrolate 9 mcg, for moterol 4.8 mcg and budesonide 160

Southern Railway has invited bids for the supply of srphc82151020-glycopyrrolate 0.2mg/ml inj 1ml amp [quantity tolerance (+/-): 5 %age , item category : normal , total po value variation permitted: max 8 la cs ] ] achd/drug.store/rh/per, sr - 1) srphc82151025-glycopyrolate 0.5 mg + neostigmine methyl sulphate 2.5 mg inj 5 ml amp, 2) srphc82151020-glycopyrrolate 0.2mg/ml inj 1 ml amp, 3) srphc82185434-glycopyrrolate 25mcg inhalation solution of 1ml respule s, 4) srphc82185450 glycopyrrolate 9 mcg, for moterol 4.8 mcg and budesonide 160 mcg inhaler, 120 mdi canister & 5) srphc82185470-indacaterol 110 mcg + glycopyrronium 50 mcg cap.. Please refer to the tender document for project value and EMD details. Interested bidders can submit applications until 26 October 2026, with the technical opening scheduled for 26 October 2026.